GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (XSWX:COPN) » Definitions » Shiller PE Ratio

Cosmo Pharmaceuticals NV (XSWX:COPN) Shiller PE Ratio : 22.45 (As of Apr. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Cosmo Pharmaceuticals NV Shiller PE Ratio?

As of today (2024-04-26), Cosmo Pharmaceuticals NV's current share price is CHF71.60. Cosmo Pharmaceuticals NV's E10 for the fiscal year that ended in Dec22 was CHF3.19. Cosmo Pharmaceuticals NV's Shiller PE Ratio for today is 22.45.

The historical rank and industry rank for Cosmo Pharmaceuticals NV's Shiller PE Ratio or its related term are showing as below:

XSWX:COPN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.61   Med: 31.48   Max: 209.1
Current: 22.38

During the past 13 years, Cosmo Pharmaceuticals NV's highest Shiller PE Ratio was 209.10. The lowest was 10.61. And the median was 31.48.

XSWX:COPN's Shiller PE Ratio is ranked better than
54.05% of 518 companies
in the Drug Manufacturers industry
Industry Median: 24.12 vs XSWX:COPN: 22.38

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cosmo Pharmaceuticals NV's adjusted earnings per share data of for the fiscal year that ended in Dec22 was CHF1.035. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is CHF3.19 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cosmo Pharmaceuticals NV Shiller PE Ratio Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV Shiller PE Ratio Chart

Cosmo Pharmaceuticals NV Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.17 26.14 30.20 21.63 19.19

Cosmo Pharmaceuticals NV Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 21.63 - 19.19 -

Competitive Comparison of Cosmo Pharmaceuticals NV's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cosmo Pharmaceuticals NV's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cosmo Pharmaceuticals NV's Shiller PE Ratio falls into.



Cosmo Pharmaceuticals NV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cosmo Pharmaceuticals NV's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=71.60/3.19
=22.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Pharmaceuticals NV's E10 for the fiscal year that ended in Dec22 is calculated as:

For example, Cosmo Pharmaceuticals NV's adjusted earnings per share data for the fiscal year that ended in Dec22 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec22 (Change)*Current CPI (Dec22)
=1.035/115.4249*115.4249
=1.035

Current CPI (Dec22) = 115.4249.

Cosmo Pharmaceuticals NV Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 5.879 99.875 6.794
201412 6.043 99.576 7.005
201512 18.482 99.676 21.402
201612 1.255 99.676 1.453
201712 -2.559 100.075 -2.952
201812 -1.354 100.773 -1.551
201912 -1.822 102.068 -2.060
202012 -0.590 101.072 -0.674
202112 1.334 106.653 1.444
202212 1.035 115.425 1.035

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cosmo Pharmaceuticals NV  (XSWX:COPN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cosmo Pharmaceuticals NV Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmo Pharmaceuticals NV (XSWX:COPN) Business Description

Traded in Other Exchanges
Address
Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2
Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.

Cosmo Pharmaceuticals NV (XSWX:COPN) Headlines

No Headlines